TY  - JOUR

T1  - Daily oral ibandronate with adjuvant endocrine therapy in postmenopausal women with estrogen receptor-positive breast cancer: editorial commentary

JO  - Annals of Translational Medicine

UR  - https://doi.org/10.21037/atm-2023-3

PY  - 2023/03/17

AU  - Coleman R

ED  - 

DO  - DOI: 10.21037/atm-2023-3

PB  - AME Publishing Company

VL  - 12

IS  - 4

SP  - 60

EP  - 60

Y2  - 2025/10/10

ER  -